Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II)
https://bmjopen.bmj.com/content/10/6/e039097
https://gtr.ukri.org/projects?ref=MC_PC_19075
https://www.ed.ac.uk/usher/eave-ii/key-outputs/scottish-vaccine-roll-out-working-data-suggests
https://www.heraldscotland.com/news/19107740.coronavirus-scotland-vaccination-linked-substantial-reduction-hospital-admissions/
Public health Scotland
Dataset covering Scottish population of 5.4 million
A unique reference number for every individual
Link datasets, construct electronic cohort
1.2m individuals (22% of the population)
Safe haven data
Fourth week after first dose, reduced risk of hospitalisation
8 December to 15 February
1.14 million vaccines doses
21% per cent of population
Pfizer, down 84% (n = 650,000)
Oxford-AstraZeneca, down 94% (n = 490,000)
Combined reduction in over 80s
Vaccination associated with 81% reduction in hospitalisation risk in the fourth week
UK easing
https://www.bbc.co.uk/news/uk-56148160
England, schools reopen 8 March
Six from 2 households outside
Care home residents, one regular visitor
Outside area trave, 29th March
Five week gaps
Four conditions
Vaccine programme continues to go to plan
Vaccines reducing hospitalisations and deaths
Infection rates do not risk a surge in hospital admissions
New variants do not fundamentally change the risk of lifting restrictions
Four tests are currently being met
Rapid drop in cases slows down
https://covid.joinzoe.com/data#related-news
https://covid.joinzoe.com/post/rapid-drop-in-cases-slows-down
February 19, 2021
Peak of 69,000 daily new cases around the 1st January
Based on data from 14,875 antigen tests
Cases now down by 80%
Current prevalence,1 in 294 people in the UK currently have symptomatic COVID
UK R value is 0.9
England, 0.9
Wales, 1.0
Scotland, 1.0
Highest risk areas in the UK
Lancashire, Blackpool, Blackburn with Darwen, 1 in 277
Greater Manchester, 1 in 287
Liverpool City Region, 1 in 337
Cases rising, 20-39
Cases falling, 60+
Source